RedHill Biopharma (RDHL) Beginning Cash Balance: 2011-2025
Historic Beginning Cash Balance for RedHill Biopharma (RDHL) over the last 12 years, with Jun 2025 value amounting to $4.6 million.
- RedHill Biopharma's Beginning Cash Balance fell 17.09% to $4.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $4.6 million, marking a year-over-year decrease of 17.09%. This contributed to the annual value of $5.6 million for FY2024, which is 72.03% down from last year.
- Latest data reveals that RedHill Biopharma reported Beginning Cash Balance of $4.6 million as of Q2 2025, which was down 0.00% from $4.6 million recorded in Q4 2024.
- Over the past 5 years, RedHill Biopharma's Beginning Cash Balance peaked at $76.0 million during Q2 2021, and registered a low of $4.6 million during Q4 2024.
- In the last 3 years, RedHill Biopharma's Beginning Cash Balance had a median value of $5.6 million in 2024 and averaged $9.7 million.
- Its Beginning Cash Balance has fluctuated over the past 5 years, first soared by 78.53% in 2021, then crashed by 72.11% in 2023.
- Over the past 5 years, RedHill Biopharma's Beginning Cash Balance (Quarterly) stood at $29.5 million in 2021, then tumbled by 32.25% to $20.0 million in 2022, then slumped by 72.11% to $5.6 million in 2023, then declined by 17.09% to $4.6 million in 2024, then fell by 17.09% to $4.6 million in 2025.
- Its Beginning Cash Balance was $4.6 million in Q2 2025, compared to $4.6 million in Q4 2024 and $5.6 million in Q2 2024.